* Mesoblast says regains worldwide rights to cardiovascular field for its cell therapy
platform; no financial consideration to teva pharmaceuticals
The post BRIEF-Mesoblast provides update on global heart failure program appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Mesoblast says regains worldwide rights to cardiovascular field for its cell therapy
platform; no financial consideration to teva pharmaceuticals
The post BRIEF-Mesoblast provides update on global heart failure program appeared first on NASDAQ.